Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial

Fokas E, Stroebel P, Fietkau R, Ghadimi M, Liersch T, Grabenbauer G, Hartmann A, Kaufmann M, Sauer R, Graeven U, Hoffmanns H, Raab HR, Hothorn T, Wittekind C, Roedel C (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Strahlentherapie und Onkologie Urban & Vogel

Book Volume: 193

Pages Range: S31-S31

Authors with CRIS profile

Rainer Fietkau Lehrstuhl für Strahlentherapie Arndt Hartmann Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Involved external institutions

Goethe-Universität Frankfurt am Main DE Germany (DE) Universitätsklinikum Göttingen DE Germany (DE) DiaCura - Praxis für Radiologische Diagnostik, Strahlentherapie und Radioonkologie DE Germany (DE) University of Zurich / Universität Zürich (UZH) CH Switzerland (CH) Kliniken Maria Hilf GmbH DE Germany (DE) Klinikum Oldenburg DE Germany (DE) Universitätsklinikum Leipzig DE Germany (DE)

How to cite

APA:

Fokas, E., Stroebel, P., Fietkau, R., Ghadimi, M., Liersch, T., Grabenbauer, G.,... Roedel, C. (2017). Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial. (pp. S31-S31).

MLA:

Fokas, E., et al. "Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial." 2017. S31-S31.

BibTeX: Download